ReviewFrontiers in oncology2022

CDK4/6 Inhibitors in Combination Therapies: Better in Company Than Alone: A Mini Review.

Gian Luca Rampioni Vinciguerra et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.